889 related articles for article (PubMed ID: 20937184)
1. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
[TBL] [Abstract][Full Text] [Related]
2. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS
Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
5. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.
Paramasivan CN; Rehman F; Wares F; Sundar Mohan N; Sundar S; Devi S; Narayanan PR
Int J Tuberc Lung Dis; 2010 Feb; 14(2):243-6. PubMed ID: 20074419
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
Rosales S; Pineda-García L; Andino N; Almendarez N; Membreño H; Hoffner SE
Int J Tuberc Lung Dis; 2009 Dec; 13(12):1542-9. PubMed ID: 19919774
[TBL] [Abstract][Full Text] [Related]
7. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
8. Extensively drug-resistant tuberculosis in california, 1993-2006.
Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
[TBL] [Abstract][Full Text] [Related]
9. Resistance to anti-tuberculosis medications in the Horn of Africa.
Ollé-Goig JE; Codina-Grau G; Martín-Casabona N
Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114
[TBL] [Abstract][Full Text] [Related]
10. Resistance of Mycobacterium tuberculosis isolates in different populations in Greece during 1993-2002.
Kanavaki S; Mantadakis E; Nikolaou S; Papavassiliou A; Karambela S; Anagnostou S; Falagas ME; Samonis G
Int J Tuberc Lung Dis; 2006 May; 10(5):559-64. PubMed ID: 16704040
[TBL] [Abstract][Full Text] [Related]
11. Surveillance and characterization of drug-resistant
Imperiale BR; Di Giulio ÁB; Mancino MB; Zumárraga MJ; Morcillo NS
Int J Mycobacteriol; 2019; 8(3):223-228. PubMed ID: 31512597
[TBL] [Abstract][Full Text] [Related]
12. Extensively drug-resistant tuberculosis: current challenges and threats.
Jain A; Mondal R
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
[TBL] [Abstract][Full Text] [Related]
13. Multidrug- and extensively drug-resistant tuberculosis, Germany.
Eker B; Ortmann J; Migliori GB; Sotgiu G; Muetterlein R; Centis R; Hoffmann H; Kirsten D; Schaberg T; Ruesch-Gerdes S; Lange C;
Emerg Infect Dis; 2008 Nov; 14(11):1700-6. PubMed ID: 18976552
[TBL] [Abstract][Full Text] [Related]
14. Trends in Mycobacterium tuberculosis resistance, Pakistan, 1990-2007.
Hasan R; Jabeen K; Mehraj V; Zafar F; Malik F; Hassan Q; Azam I; Kadir MM
Int J Infect Dis; 2009 Nov; 13(6):e377-82. PubMed ID: 19369103
[TBL] [Abstract][Full Text] [Related]
15. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
Pitso L; Potgieter S; Van der Spoel van Dijk A
S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
[TBL] [Abstract][Full Text] [Related]
17. Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
Ramos E; Fissette K; de Rijk P; Palomino JC; Martin A
Int J Tuberc Lung Dis; 2012 Jan; 16(1):110-3. PubMed ID: 22236855
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis].
Gui XH; Xu P; Zhao M; Wang LL; Wu J; Li J; Gao Q; Mei J
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):43-5. PubMed ID: 20368024
[TBL] [Abstract][Full Text] [Related]
19. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
[TBL] [Abstract][Full Text] [Related]
20. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Coban AY; Bilgin K; Uzun M; Durupinar B
Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]